California State University, Dominguez Hills

CSUDH Home Search Index
 

CSUDH Home > College of Natural And Behavioral Science > Sociology Department

Home :: Mission Statement :: University Catalog :: Graduate Program :: Faculty :: Pipeline :: Blackboard :: CSUDH Home

 

Ricky Bluthenthal                                                                              
Director
, Urban Community Research Center
Professor,
Sociology Department

Office Hours: Monday 1-3pm
rbluthenthal@csudh.edu
Phone:  (310)-243-3500
Fax: 310-217-6855

 

 

Ricky N. Bluthenthal, Ph.D. the Director of the Urban Community Research Center and a Professor in the Sociology Department at California State University Dominguez Hills.  Dr. Bluthenthal’s major research contributions have been in the areas of HIV epidemiology and prevention for drug injectors, racial/ethnic differences in alcohol consumption, consequences, and treatment outcomes, and community approaches to health promotion.  Dr. Bluthenthal’s current research projects are funded by the City and County of Los Angeles, the California Department of Public Health, and the Centers for Disease Control and Prevention among others.  He is currently involved in research on topics as diverse as the impact of commercial activity on adolescent violence, the HIV prevention effects of nonprescription pharmacy syringe sales, individual and family outcomes associated with residential substance abuse treatment for women and their children, and the development of evidence-based practice for HIV prevention programs for injection drug users.   Most relevant for this project, he is Principal Investigator of a CDC funded cooperative agreement study that tests the efficacy of a group-level intervention for bisexual African American men.  Dr. Bluthenthal has published over 60 studies in peer-reviewed scientific journals such as the American Journal of Public Health, Addiction, Alcoholism: Clinical and Experimental Research, Social Science and Medicine, and Health Services Research.  He has also presented over 100 papers at scientific conferences, regularly reviews manuscripts for leading public health and substance abuse journals, and has served on a numerous NIH review panels including a four-year term as a standing member on the “Community Influences on Health Behavior” (formerly Community-Level Health Promotion) Study Section.  He received his doctoral degree in Sociology from the University of California, Berkeley in 1998.  Dr. Bluthenthal is also a senior social scientist at the RAND Corporation.

EDUCATION

Ph.D., Sociology, University of California, Berkeley, December 1998.
MA, Sociology, University of California, Berkeley, December 1990.
BA, History and Sociology, University of California, Santa Cruz, June 1986.

CURRENT PROJECTS

Principal Investigator. (CSUDH subcontract from RTI). International feasibility study of pharmacy-based HIV prevention: San Francisco. National Institute on Drug Abuse (NIDA). National Institutes of Health. January 2009 to December 2011.

Principal Investigator (CSUDH). The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men. Centers for Disease Control and Prevention. September 2008 to September 2012.

Principal Investigator (CSUDH). Tamar House Residential Treatment Evaluation. Shields for Families, Los Angeles, CA. November 2007 to October 2012.

Senior Research Investigator. (CSUDH). Family and cultural impact on STD and HIV risk among Latino and African American Youth – Minority AIDS Research Initiative. CDC. (PI: Carl D. Sneed). September 2007 to September 2011.

Principal Investigator (RAND). Policy simulation models of the HIV epidemic in Central America. UCLA AIDS Institute. July 2007 to June 2008.

Principal Investigator (CSUDH). Evaluation of syringe exchange services. Office on AIDS, City of Los Angeles. July 1, 2007 to June 30, 2009.

Principal Investigator (CSUDH). Syringe exchange program evaluations. Department of Public Health, Los Angeles County. July 2007 to June 2009.

Principal Investigator (CSUDH). The influence of pharmacy-based syringe disposal on unsafe syringe discard among injection drug users in California. State Office on AIDS, California Department of Health Services. September 2006 to August 2009.

Principal Investigator (CSUDH).  Evaluation of Harm Reduction Coalition Technical Assistance to Syringe Exchange Programs. Harm Reduction Coalition, September 2006 to August 2009.

Principal Investigator (CSUDH). Evaluation of SB1159 Implementation in Los Angeles County. Drug Policy Alliance, September 2006 to August 2009.

Co-Principal Investigator (RAND). The Impact of Business Improvement Districts on Youth Violence. Centers for Disease Control and Prevention (CDC). (Co-PI: John MacDonald). October 2005 to September 2009.
           
Principal Investigator (RAND). Impact of Business Improvement Districts on Mortality. CDC. (Co-PI: John MacDonald). September 1, 2007 to August 31, 2008.

Co-Investigator. (RAND). Urban Congregations’ Capacity for HIV Prevention & Care. National Institute on Child and Human Development (NICHD). (PI: Kathryn Derose). May 2005 to April 2010.

GRANT HISTORY(as PI only, last 3 years)

“The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men.” CDC, 2008 -12. ~$973,868.

“Tamar House Residential Treatment Evaluations.” Shields for Families, 2007-12. $500,000.

“Impact of Business Improvement Districts on Mortality.” CDC, 2007-08. $89,777.

“Policy simulation models of the HIV epidemic in Central America.” UCLA AIDS Institute, 2007-08. $30,000.

“Evaluation of syringe exchange services.”Office on AIDS, City of Los Angeles. 2007-09. $21,622.

“Syringe exchange program evaluations.” Department of Public Health, Los Angeles County. 2007-09. $100,000.

“The influence of pharmacy-based syringe disposal on unsafe syringe discard among injection drug users in California.” State Office on AIDS, California Department of Health Services, 2006-09. $450,000.

“Evaluation of Harm Reduction Coalition Technical Assistance to Syringe Exchange Programs.” Harm Reduction Coalition, Oakland, CA. 2006-09. $55,000.

“Evaluation of SB1159 Implementation in Los Angeles County.” Drug Policy Alliance, 2006-09. $39,000.

“Targeted HIV prevention and expansion.” Shields for Families, 2002-2007. $375,000

 

COMPLETED PROJECTS (last 3 years)

Co-Investigator. (CSUDH). GIS, Alcohol Marketing, and Alcohol-Related Outcomes. National Institute on Alcohol Abuse and Alcoholism (NIAAA). (PI: Deborah A. Cohen). September 2003 to July 2008.

Principal Investigator. (RAND). Community context, SEP operations, & HIV risk among IDUs. National Institute on Drug Abuse (NIDA). September 2002 to November 2007.

Principal Investigator. (RAND). Community context, SEP operations, & HIV risk among IDUs. NIDA - minority doctoral supplement for Alexis Martinez. September 2003 to October 2006.

Principal Investigator. (RAND). Community context, HIV prevention, & HIV risk among IDUs. NIDA – supplement application to the Office on AIDS FY 2003 HIV Prevention Science Initiative. June 2003 to May 2004.

Principal Investigator (Drew). Targeted HIV prevention and expansion. Shields for Families, September 2002 to October 2007.

PUBLICATIONS (last 3 years)

Peer-reviewed Journals

  1. Jacobson JO, Robinson P, Bluthenthal RN. A multilevel decomposition approach to estimate the role of program location and neighborhood disadvantage in racial disparities in alcohol treatment completion. Social Science and Medicine. 2007;64(2):462-76.
  2. Jacobson JO, Robinson P, Bluthenthal RN. Understanding racial disparities in alcohol treatment outcomes: Addiction severity, demographics, and economic factors do not fully explain differences in retention. Health Services Research. 2007; 42(2):773-94.
  3. Bluthenthal RN, Ridgeway G, Schell T, Flynn NM, Anderson R, Kral AH. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction. 2007; 102(4):638-46.
  4. Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn NM, Kral AH. The impact of legalizing syringe exchange programs on arrest among injection drug users in California. Journal of Urban Health. 2007; 84 (3):423-35.
  5. Stopka TJ, Marshall C, Bluthenthal RN, Webb DS, Truax SR. HCV and HIV counseling and testing integration in California: An innovative approach to increase HIV counseling and testing rates. Public Health Reports. 2007; 122 (Supplement 2):68-73.
  6. Heinzerling KG, Kral AH, Scott A, Gilbert ML, Anderson R, Flynn NM, Bluthenthal RN.  Human immunodeficiency virus and hepatitis C virus testing at syringe exchange programs: Availability and outcomes. Journal of Substance Abuse Treatment. 2007; 32(4):423-9.
  7. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence. 2007; 89(2-3):214-22.
  8. Bluthenthal RN, Jacobson JO, Robinson PL. Are racial disparities in alcohol treatment completion associated with treatment modality entry? Comparison of outpatient and residential treatment in Los Angeles County, 1998 to 2000. Alcoholism: Clinical and Experimental Research. 2007; 31 (11):1920-26.                                                                              
  9. Bluthenthal RN, Do P, Finch B, Martinez A, Edlin BR, Kral AH. Community characteristics associated with HIV risk among injection drug users: A multi-level analysis. Journal of Urban Health. 2007; 84(5):653-66.
  10. Cohen D, Schoeff D, Farley TA, Bluthenthal RN, Scribner R, Overton A. Reliability of a store observation tool in measuring availability of alcohol and selected foods. Journal of Urban Health. 2007; 84(6):807-13.
  11. Bluthenthal RN, Heinzerling KG, Flynn NM, Anderson R, Kral AH. Approval of syringe exchange programs in California: Mixed results from a local approach to HIV prevention. American Journal of Public Health. 2008; 98(2):278-83. 
  12. Bluthenthal RN, Cohen DA, Farley TA, Scribner R, Beighley C, Schonlau M, Robinson PL. Alcohol availability and neighborhood characteristics in Los Angeles, California and Southern Louisiana.  Journal of Urban Health. 2008; 85(2):191-205.
  13. Scott MM, Cohen DA, Schonlau M, Farley TA, Bluthenthal RN. Alcohol and tobacco marketing: Evaluating compliance with outdoor advertising guidelines. American Journal of Preventive Medicine. 2008:35(3):203-9.
  14. Schonlau M, Scribner R, Farley TA, Theall KP, Bluthenthal RN, Scott M, Cohen DA. Alcohol outlet density and alcohol consumption in Los Angeles and Southern Louisiana. Geospatial Health. 2008; 3(1):91-101.
  15. Theall KP, Scribner R, Cohen D, Bluthenthal RN, Schonlau M, Farley TA. Access to social capital and the neighborhood alcohol environment. Health and Place. 2009; 15:323-32.
  16. Vilamovska AM, BrownTaylor D, Bluthenthal RN. Adverse Drinking-Related Consequences among Malt Liquor Beer Drinkers in a Low-Income, Ethnic Minority Community Sample. Alcoholism: Clinical and Experimental Research. 2009; 33(4):645-53.
  17. Robinson PL, Boscardin WJ, George SM, Teklehaimanot S, Heslin KC, Bluthenthal RN. The effect of urban street gang densities on small area homicide incidence in a large metropolitan county, 1994-2002. Journal of Urban Health. 2009: In press.
  18. Kral AH, Lorvick J, Martinez A, Lewis M, Anderson R, Flynn NM, Bluthenthal RN. HIV prevalence and risk among heterosexual methamphetamine injectors in California. Substance Use & Misuse. (In press).
  19. Martinez AN, Bluthenthal RN, Flynn NM, Anderson R, Kral AH. HIV risk and health service utilization among Mexican and Mexican American injection drug users in California. AIDS and Behavior. (In press).
  20. Cohen DA, Sturm R, Scott M, Farley TA, Bluthenthal RN. Is eating more fruits and vegetables associated with lower consumption of cookies, candy, salty snacks, or soda? Implications for obesity control from Los Angeles and Louisiana. Public Health Reports. (In press).

                                                                                                          
Books, Book Chapters, Journal Special Issues, and Monographs

Bikson TK, Bluthenthal RN, Eden R, Gunn PP, Editors. Ethical Principles in Social-Behavioral Research on Terrorism: Probing the Parameters. RAND Corporation Working Papers: Santa Monica, CA. September 2007.  

Sharma M, Burrow D, Bluthenthal RN, Editors. Coverage of programs addressing HIV/AIDS among injecting drug users – Special Issue of International Journal of Drug Policy. 2008; 19 (Supplement 1).

Bluthenthal RN. Needle exchange programs. Pp. 629-32. In Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery. Edited by Fisher GL, Roget NA. Thousand Oaks, CA: Sage Publications, 2008.

MacDonald J, Bluthenthal RN, Golinelli D, Kofner A, Stokes R, Sehgal A, Fain T. Neighborhood Effects on Crime and Youth: The role of Business Improvement Districts in Los Angeles. RAND Corporation Technical Report (TR-622-CDC): Santa Monica, 2009.

Letters, Commentaries, and Reviews

Sharma M, Burrow D, Bluthenthal RN. Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward. International Journal of Drug Policy. 2007; 18:92-98.

Sharma M, Burrow D, Bluthenthal RN. Improving coverage and scale-up of HIV prevention, treatment and care for injecting drug users: Moving the agenda forward. International Journal of Drug Policy. 2008; 19(Suppl 1):S1-S4.  

PAPER PRESENTATIONS (last 3 years)

Kral AH, Martinez A, Lorvick J, Wenger L, Anderson R, Flynn NM, Bluthenthal RN. “HIV risk among heterosexual methamphetamine injectors in California.” Second National Conference on Methamphetamine, HIV and Hepatitis. Salt Lake City, Utah, February 1-3, 2007.

Bluthenthal RN, Anderson R, Flynn NM, Kral AH. “Do methamphetamine injectors differ from other injection drug users? Evidence from the CalSEP study.” Second National Conference on Methamphetamine, HIV and Hepatitis. Salt Lake City, Utah, February 1-3, 2007.

Bluthenthal RN, Cohen DA, Farley T, Scribner R, Beighley C, Schonlau M, Robinson PL. “Alcohol availability and neighborhood characteristics in Los Angeles and Southern Louisiana.” One Hundred Thirty-Fifth Annual Meeting of the American Public Health Association, Washington, D.C., November 3-7, 2007.

MacDonald J, Golinelli D, Bluthenthal RN. “The effect of business improvement districts on community violence.” American Society of Criminology. Atlanta, GA, November 14-17, 2007.

Bluthenthal RN, Sneed CD, Kral AH. “Does syringe coverage percentage mediate the association between syringe exchange program (SEP) dispensing policies and HIV/HCV risk in a cohort of injection drug users (IDUs)?” Harm Reduction 2008: IHRA’s 19th International Conference. Barcelona, Spain, May 11-15, 2008.

Kral A, Anderson R, Flynn N, Lorvick J, Bluthenthal R. “Is more liberal syringe dispensing associated with unsafe syringe disposal? Evidence from the California Syringe Exchange Program Study (CalSEP).” 17th International AIDS Conference. Mexico City, Mexico, August 3-8, 2008.

Schonlau M, Cohen D, Scribner R, Farley TA, Theall K, Bluthenthal RN, Scott M. Alcohol outlet density and alcohol consumption in Los Angeles County and Southern Louisiana. 2008 Joint Statistical Meetings. Denver, CO, August 5, 2008.

Derose Pitkin K, Mendel PJ, Casteneda LW, Oden CW, Mata M, Bluthenthal RN, Dominguez B, Palar K, Kanouse DE. “Exploring urban congregations’ capacity for HIV prevention & care: A case study analysis.” 136th Annual Meeting of the American Public Health Association. San Diego, CA. October 25-29, 2008.

Garfein RS, Stopka TJ, Pavlinac PB, Ross A, Haye K, Riley ED, Bluthenthal RN. “Three Years into Legalization of Over-the-Counter (OTC) Syringe Sales in California (SB1159). Where are we now?” 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

Cooper E, Dodson C, Guentzel HG, Stopka TJ, Riley ED, Garfein RS, Bluthenthal RN. “Uptake of over-the-counter pharmacy sales in Los Angeles and San Francisco:  Factors associated with pharmacy participation in SB1159.” 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

Stopka TJ, Nonoyama A, Ruiz J, Garfein RS, Riley ED, Bluthenthal RN. “Syringe sources utilized by IDUs in California pre- and post-implementation of a pharmacy-based syringe sales initiative.” 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

Riley ED, Kral A, Garfein RS, Stokpka TJ, Bluthenthal RN. “Pharmacies Provide Substantial Augmentation to San Francisco Needle Exchange Programs One Year after SB1159.” 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

Sturm R, Cohen DA, Farley TA, Bluthenthal RN. “Cookies, candy, salty snacks, soda and alcohol: Discretionary calories in two communities.” 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

MacDonald JM, Stokes R, Bluthenthal RN, Golinelli D. A mixed method approach to studying the relationship between business improvement districts and youth violence. 136th Annual Meeting of the American Public Health Association. San Diego, CA, October 25-29, 2008.

MacDonald J, Bluthenthal RN, Golinelli D, Kofne A, Stokes RJ. “The impact of business improvement districts on neighborhood-level youth violence.” Association for Public Policy Analysis and Management (APPAM). Los Angeles, CA, November 6-8, 2008.

Bluthenthal RN, Kral AH. Recommended preventive service utilization among injection drug users (IDUs) who do and do not use syringe exchange programs (SEPs). 7th National Harm Reduction Conference. Miami, FL, November 13-16, 2008.

Kral AH, Wenger LD, Carpenter L, Bourgois P, Iguchi M, Bluthenthal RN. Late injection drug use initiators: Epidemiological trends and risk factors. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno, NV, June 20-25, 2009. 

Bluthenthal RN, Wenger LD, Bourgois P, Iguchi M, Kral AH.  Regional variations and factors associated with late injection drug use initiation in California. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno, NV, June 20-25, 2009. 

INVITED AND OTHER SPEAKING (last 3 years)

“Overview of SEPs in California and the U.S.” 5th Annual Inland Empire HIV Conference. Cabazon, CA, March 11, 2009.

“Research and science supporting effectiveness of syringe exchange programs: Ending the ban on federal funding of syringe exchange preventing HIV and Hepatitis C in our communities.” Congressional Briefing, Rayburn Office Building. Washington, D.C., February 18, 2009.

“Effect of Business Improvement Districts (BIDs) on Violent Crime in Los Angeles.” With John MacDonald. Congressional Briefing. “Reducing Violent Crime at Places: The Research Evidence. Center for Evidence-based Crime Policy. Senate Russell Building, SR385. Washington, D.C., February 3, 2009.

“Faculty-Student Research and Mentorship Special Focus: McNair Scholars Program in the California State University.” California State University Board of Trustees Meeting. Long Beach, California, November 19, 2008.

“Policy Implications of Research on Prisoner Health and Risk Behavior – What’s Going on Inside and Can Research Change Policy?” Health Justice Action Conference 2008. Center for Health Justice. Universal City, California. August 22, 2008.

“An HIV prevention policy research agenda for injection drug users.” With Alex H. Kral. Establishing Evidence for Social & Behavioral HIV Prevention. California HIV/AIDS Research Program, California State Office of AIDS, & San Francisco AIDS Foundation. San Francisco, CA. March 6-7, 2008.

“Harm reduction and syringe exchange programs: A review of the evidence.” Los Angeles County Bar Association Bioethics Committee. Los Angeles, California. November 14, 2007.

PROFESSIONAL MEMBERSHIPS AND SERVICE (last 3 years)

Member, Program Committee, Pacific Sociological Association 2009 Annual Meeting. San Diego, California, 2009.

Member, Subpart A Subcommittee, Secretary’s Advisory Committee on Human Research Protections (SACHRP), Department of Health and Human Services. (2007 to 2008)

Member, California HIV/AIDS Research Program Advisory Council (formerly Universitywide AIDS Research Program). University of California Office of the President. (2007 to 2008)
            Chair, Input and solicitations subcommittee

Member, Science Committee, National Harm Reduction Conference, Miami, Florida, November 13-16, 2008.

Member, Program Committee, Pacific Sociological Association 2007 Annual Meeting. Oakland, California, March 28-April 1, 2007.

Member, International Programme Advisory Group, 17th and 18th International Conference on the Reduction of Drug Related Harm. Vancouver, Canada; Barcelona, Spain. 2005 to 2008.

Regular Member, Human Subjects Protection Committee, RAND, Santa Monica, CA. (Alternate Member 2001 to 2004). 2001 to present

Member, Pacific Sociological Association, Sacramento, California. 2007 to present

Member, Research Society on Alcoholism, Austin, Texas. 1999 to present.

Member, Society for the Study of Social Problems, Knoxville, Tennessee. 1998 to present.
            Minority Scholarship Award Committee, 2001.

Member, American Public Health Association, Washington, D.C. 1997 to present.

Member, American Sociological Association, Washington, D.C. 1993 to present

REVIEWER (last 3 years)

Journals

Addiction, AIDS and Behavior, Alcoholism: Clinical and Experimental Research, American Journal of Public Health, American Journal of Preventive Medicine, Archives of General Psychiatry, BioMed Central (BMC) Public Health, Drug and Alcohol Dependence, Evaluation and Program Planning, Harm Reduction Journal,  International Journal of Drug Policy, Journal of Acquired Immune Deficiency Syndromes, Journal of Adolescent Health, Journal of Behavioral Medicine, Journal of Studies on Alcohol and Drugs, Journal of the American Medical Association, Journal of the International AIDS Society, Journal of Urban Health,  Progress in Community Health Partnership: Research, Education, and Action,  Social Science and Medicine, Substance Abuse Treatment, Prevention, and Policy, Substance Use & Misuse.

Conferences

California Sociological Association Meeting
International AIDS Conference
International Conference on the Reduction of Drug Related Harm
National Harm Reduction Conferences
National HIV Prevention Conferences

Grant-making Institutions

North American Syringe Exchange Network Annual Funding Cycle (2001 to present).
Special Emphasis Panel – Unintentional Poisoning From Prescription Drug Overdoses in Adults, National Center on Injury Prevention and Control, CDC. (2009).
National Institute on Drug Abuse, Avant Garde Awards, 2009/08 ZDA 1 NXR-B(08)1. (2009).
Special Emphasis Panel – Elimination of Health Disparities through Translation Research. CDC. (2008).
Center for Scientific Review, Risk, Prevention and Intervention for Addictions (RPIA) Study Section, NIH (February and June, 2008).
Center for Scientific Review, Special Emphasis Panel – Health of the Population (HOPX02M and HOPX04M), NIH (2007).
Tides Foundation, Syringe Access Fund (2007).
Rapid Assessment Post Impact of Disaster ZMH1 ERB-P, National Institute on Mental Health (2005).
Behavioral Science Seed Grant Applications, UCLA AIDS Institute (2005; 2008).

VOLUNTEER ACTIVITIES (last 3 years)

Member, Advisory Committee, South Los Angeles Health Disparities Scorecard, Community Health Councils, Los Angeles, CA. (2007 to 2008)

Advisory Board Member, North American Syringe Exchange Network. Tacoma, WA. April 2000 to present.

California State University, Dominguez Hills • 1000 E. Victoria Street • Carson, California 90747 • (310) 243-3696
If any of the material is in violation of a copyright, please contact copyright@csudh.edu.
Last updated: August 30, 2006 by mk